Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Stent price caps to save Rs. 4,450 crore annually

HIV and Cancer Drugs to become affordable
25 Dec 2015
  • The health ministry has added 47 drugs for cancer and 22 for HIV to the latest National Essential Medicines List ( NELM), bringing the total count of essential medicines under price control to 530.
  • Essential drugs satisfy the priority needs of majority of the population and government ensures their quality control and access.
  • Ceiling prices have been levied on unscheduled cardiovascular drugs as well.

  • NPPA fixes ceiling rates, 56 drugs to get cheaper
    6 Jun 2016
  • The government has capped the price of important medicines used in the treatment of cancer, diabetes, blood pressure etc.
  • The cost will be reduced by an average of 25%.
  • The products of almost all big pharmaceutical companies will be affected by the new price cap announced by the drug price regulator National Pharmaceutical Pricing Authority (NPPA).

  • Prices of essential drugs slashed
    24 Dec 2016
  • The prices of 50 essential drugs, used to treat HIV, diabetes, anxiety, bacterial infections, angina and acid reflux have been slashed by 5% to 44%.
  • The National Pharmaceutical Pricing Authority said they revised ceiling prices of 55 formulations of Schedule-I drugs and retail prices of 29 formulations.
  • The average reduction in prices for all the drugs is approximately 25%.

  • NPPA seeks separate bills for stents, caps prices
    15 Feb 2017
  • National Pharmaceutical Pricing Authority has asked hospitals, clinics and nursing homes to compulsorily bill patients separately for coronary stents, and display their prices publicly.
  • Bare metal stents will now cost maximum Rs 7,260, and drug-eluting (DES) and biodegradable stents Rs 29,600. Currently, DES prices vary from Rs 35,000-Rs 1.95 lakh, and biodegradable, around Rs 1.80 lakh.
  • 90% stents used in India are DES.

  • Govt to now monitor prices of medical devices
    08 Mar 2017
  • After stents, the National Pharmaceutical Pricing Authority is now creating a database to monitor prices of all drugs and medical devices likely to be overcharged by hospitals and manufacturers.
  • The list of monitored items includes all devices considered drugs under the Drugs and Cosmetics Act (catheters, syringes, HIV devices etc).
  • At a meeting next week, government will discuss the issue with industry representatives.

  • Stent price caps to save Rs. 4,450 crore annually
    16 Mar 2017
  • The government has stated that the cap on prices of medical stents in India would save up to Rs. 4,450 crore per year for patients.
  • Minister of state for chemicals Mansukh L Mandaviya said regulations reduced prices of "bare metal stent by 74% and that of drug-eluting stents by 85%".
  • The government has issued notifications to all hospitals to adhere to the prices.

  • This post first appeared on NewsBytes: Latest News, Breaking News India, Today News, Current News, please read the originial post: here

    Share the post

    Stent price caps to save Rs. 4,450 crore annually


    Subscribe to Newsbytes: Latest News, Breaking News India, Today News, Current News

    Get updates delivered right to your inbox!

    Thank you for your subscription